the benefits of glp 1 drugs beyond obesity Popular GLP-1 help many people drop tremendous amounts weight. But @uvaschoolofmedicine experts warn in a new paper drugs fail to provide a key improvement in heart and lung function The World Health Organization has

A phase II study result showed that administering a high dose of survodutide, up to 1.8 mg twice weekly, resulted in over 50% of T2D participants achieving more than 5% body weight reduction, and over 25% experiencing a weight loss exceeding 10% [111]

2 Data show that more than 50% of patients started on monotherapy will require a second medication to control diabetes after three years

But having diabetes also puts a person at increased risk for developing gastroparesis, so its difficult to know if the risks would look the same for people who dont have the condition

Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity

Rhea, E

Keep an eye out for official domains and secure certificates